The authors compared loxapine with chlorpromazine in inpatients with
paranoid schizophrenia and found no difference in clinical efficacy. Thus a
previous finding, based on retrospective analyses, that loxapine was
superior to other neuroleptics in the treatment of paranoid schizophrenia
was not verified in this prospective study.
Abstract Teaser